← All Stories
Regulatory

Bridgewater Pure Alpha Fund IV Files SEC Document Under Section 3(c)(7)

Bridgewater Pure Alpha Fund IV (DE), LP filed a SEC document on April 24, 2026, related to Item 3C.7 under Section 3(c)(7) of the Investment Company Act.

Detailed view of a financial report with a focus on graphs and data analysis.
Photo by RDNE Stock project on Pexels

Bridgewater Pure Alpha Fund IV Submits SEC Filing

On April 24, 2026, Bridgewater Pure Alpha Fund IV (DE), LP filed a document with the SEC, as indicated by Accession Number 0000905148-26-001820. The filing includes Item 3C, specifically Item 3C.7 related to Section 3(c)(7) of the Investment Company Act. This filing was made by the entity with CIK 0002058151, according to SEC EDGAR.

Details of the Filing

The document, titled D/A - Bridgewater Pure Alpha Fund IV (DE), LP, has a file size of 9 KB. It explicitly references Item 3C.7, which pertains to Section 3(c)(7). As is widely known, Section 3(c)(7) is part of the Investment Company Act that applies to certain private funds. The filing was submitted through the SEC’s EDGAR system on the specified date.

Fund and Regulatory Aspects

Bridgewater Pure Alpha Fund IV (DE), LP is the filer identified in the document. The filing’s Accession Number is 0000905148-26-001820, and it directly ties to Item 3C of the Investment Company Act. According to SEC EDGAR, this reflects the fund’s engagement with regulatory requirements. The source material confirms the involvement of Section 3(c)(7) in the filing process.

Sources
Topics
Get capital raising signals before they hit the news.
Join Waitlist